- Last edited on February 7, 2022
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision Next revision Both sides next revision | ||
cl:psychiatric-side-effects-of-medications [on February 5, 2019] |
cl:psychiatric-side-effects-of-medications [on February 7, 2022] psychdb [Offending Agents] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Psychiatric Side Effects of Medications and Substances ====== | ====== Psychiatric Side Effects of Medications and Substances ====== | ||
+ | {{INLINETOC}} | ||
===== Primer ===== | ===== Primer ===== | ||
- | Medications and recreational substances can have profound psychiatric symptoms for patients. | + | Medications and recreational substances can sometimes induce psychiatric syndromes, including depression, anxiety, mania/hypomania, sleep, and cognitive impairment. Thus, it is important to ensure that these iatrogenic effects are not mistaken for a "primary" psychiatric disorder. |
- | == Medications with Depression as a Side Effect == | + | ===== Offending Agents ===== |
- | * [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/|Tango, R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience, 5(2), 155.]] | + | * Individuals may experience changes in mood, cognition, memory, or behaviour during glucocorticoid treatment or withdrawal.[([[https://www.ncbi.nlm.nih.gov/pubmed/25272344|Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., ... & Joëls, M. (2014). Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. American Journal of Psychiatry, 171(10), 1045-1051.]])] |
- | * [[https://jamanetwork.com/journals/jama/fullarticle/2684607|Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]] | + | ===== Cognition ===== |
- | + | The diagnosis for a **Substance/Medication-Induced Major or Mild Neurocognitive Disorder** is as follows: | |
- | ===== Substance/Medication-Induced Major or Mild Neurocognitive Disorder ===== | + | |
<WRAP group> | <WRAP group> | ||
<WRAP half column> | <WRAP half column> | ||
Line 48: | Line 48: | ||
</WRAP> | </WRAP> | ||
+ | ===== Depression ===== | ||
+ | <alert type="info" icon="fa fa-book fa-lg fa-fw"> | ||
+ | See also: | ||
+ | * **[[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/|Tango, R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience, 5(2), 155.]]** | ||
+ | * **[[https://jamanetwork.com/journals/jama/fullarticle/2684607|Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]]** | ||
+ | </alert> | ||
+ | |||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See main article: **[[mood:substance-medication|]]** | ||
+ | </alert> | ||
+ | |||
+ | ===== Mania/Hypomania ===== | ||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See main article: **[[bipolar:substance-medication|]]** | ||
+ | </alert> | ||
+ | |||
+ | ===== Anxiety ===== | ||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See main article: **[[anxiety:substance-medication|]]** | ||
+ | </alert> | ||
+ | |||
+ | ===== Sleep ===== | ||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See main article: **[[sleep:substance-medication|]]** | ||
+ | </alert> | ||
+ | |||
+ | ===== Sexual Dysfunction ===== | ||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See main article: **[[sexual-dysfunctions:substance-medication|]]** | ||
+ | </alert> | ||